Toggle Main Menu Toggle Search

Open Access padlockePrints

The Newcastle University research output collection, currently available on ePrints, will shortly be moving to a new open repository platform, Figshare. To prepare for the data migration we have paused adding new content to ePrints, and will resume once the new repository is launched. During this time you will continue to have access to ePrints (but no new content will appear). We will share updates here when available.

Dominant-Negative Versus Gain-of-Function STAT3 Defects: A Systematic Review on Epidemiological, Clinical, Immunological, and Molecular Aspects

Lookup NU author(s): Dr Christo TsilifisORCiD, Professor Andrew GenneryORCiD

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


Abstract

© 2025 American Academy of Allergy, Asthma & Immunology. Background: Germline signal transducer and activator of transcription 3 (STAT3) mutations cause 2 distinct syndromes with predominant infectious or autoimmune phenotype. Objective: The objective of this study is to compile literature reports on gain-of-function (GOF) and dominant-negative (DN) mutations in the STAT3. Methods: We searched 3 main databases including PubMed, Scopus, and Web of Science from 1990 to 2023. All full-text articles and major reviews were manually searched for additional studies. Results: A total of 490 patients were reported in 107 articles including 265 patients with DN-STAT3 and 225 patients with GOF-STAT3 mutations. Major clinical differences between STAT3-DN and STAT3-GOF patients were observed in rates of infectious complication (98.2% vs 85.4%, P <. 001), pneumonia (67.3% vs 52.1%, P =. 006), sinusitis (17.5% vs 2.1%, P <. 001), otitis (27.7% vs 5.2%, P <. 001), abscess (52.7% vs 17.7%, P <. 001), dermatologic manifestation (88.3% vs 58.4%, P <. 001), atopic disorders (66.4% vs 40.2%, P <. 001), interstitial lung disease (0.7% vs 17.7%, P <. 001), dental/gingival disorders (38.5% vs 11.7%, P <. 001), and endocrinopathies (0.9% vs 16.5%, P <. 001), respectively. Most patients had normal counts of lymphocyte subsets, with the exceptions of higher CD3+ T cells and lower natural killer cells in STAT3-DN patients, and lower CD4+ T cells in STAT3-GOF patients. Most STAT3-DN patients had either normal or high serum concentrations of IgG, IgA, and IgM with almost universal raised serum IgE. Most STAT3-GOF patients had a low level of IgG, but normal levels of IgA, IgM, and IgE. Conclusions: Patients with STAT3-DN had recurrent dermatological and pulmonary infections, eczema, elevated IgE, and eosinophilia, whereas patients with STAT3-GOF had early-onset polyautoimmunity and frequently require immunosuppressive therapy.


Publication metadata

Author(s): Hajialigol A, Azizi G, Seifi Alan M, Soltani A, Arabian Z, Tamiji M, Tsilifis C, Gennery AR, Jamee M

Publication type: Article

Publication status: Published

Journal: Journal of Allergy and Clinical Immunology: In Practice

Year: 2025

Volume: 13

Issue: 6

Pages: 1440-1448

Print publication date: 01/06/2025

Online publication date: 15/04/2025

Acceptance date: 07/04/2025

ISSN (print): 2213-2198

ISSN (electronic): 2213-2201

Publisher: Elsevier BV

URL: https://doi.org/10.1016/j.jaip.2025.04.014

DOI: 10.1016/j.jaip.2025.04.014

PubMed id: 40246075


Altmetrics

Altmetrics provided by Altmetric


Share